This paper is in the following e-collection/theme issue:

Development of Instruments and Surveys (86) Participatory Research Protocols and Proposals (142)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43091, first published .
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Authors of this article:

Laurie Fraticelli1 Author Orcid Image ;   Julie Freyssenge2 Author Orcid Image ;   Emilie Promé-Combel3 Author Orcid Image ;   Eléonore Agnellet4 Author Orcid Image ;   Yesim Dargaud3 Author Orcid Image ;   Valérie Chamouard3, 4 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.